Bausch & Lomb (TSX:BLCO) Other Net Income (Loss) : C$0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2022. Start your Free Trial

What is Bausch & Lomb Other Net Income (Loss)?

Bausch & Lomb's Other Net Income (Loss) for the three months ended in Mar. 2025 was C$0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2025 was C$0 Mil.

Bausch & Lomb's quarterly Other Net Income (Loss) increased from Sep. 2024 (C$-0 Mil) to Dec. 2024 (C$0 Mil) and increased from Dec. 2024 (C$0 Mil) to Mar. 2025 (C$0 Mil).

Bausch & Lomb's annual Other Net Income (Loss) declined from Dec. 2022 (C$0 Mil) to Dec. 2023 (C$0 Mil) but then stayed the same from Dec. 2023 (C$0 Mil) to Dec. 2024 (C$0 Mil).

Bausch & Lomb Other Net Income (Loss) Historical Data

The historical data trend for Bausch & Lomb's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch & Lomb Other Net Income (Loss) Chart

Bausch & Lomb Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Net Income (Loss)

Get a 7-Day Free Trial

Bausch & Lomb Quarterly Data
	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Net Income (Loss)	Get a 7-Day Free Trial														-	-	-	-	-

Bausch & Lomb Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0 Mil.

Bausch & Lomb Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Bausch & Lomb's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Bausch & Lomb Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bausch & Lomb Corp (TSX:BLCO) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

BLCO:USA

Address

520 Applewood Crescent, Vaughan, ON, CAN, L4K 4B4

Website

https://www.bausch.com

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Executives